Amlodipine Cost in Montana 2026: Cash Prices, Medicaid, and Insurance

What Does Amlodipine Actually Cost in Montana in 2026?

Generic amlodipine is one of the least expensive prescription medications available in Montana. Cash-pay prices at major chains and independent pharmacies average about $8 per month for a 30-tablet supply of 5 mg or 10 mg tablets. That figure already places it within reach for most patients without insurance, and several programs can reduce the price even further.

Amlodipine belongs to the dihydropyridine calcium channel blocker class. The FDA approved the original brand Norvasc (Pfizer) in 1992, and generic versions have been available since 2007. The FDA label for amlodipine besylate lists approved indications as hypertension, chronic stable angina, and confirmed or suspected vasospastic (Prinzmetal's) angina [1].

Because the patent expired more than 17 years ago, every major pharmacy chain in Montana carries at least one generic formulation. Retail prices vary modestly by city. Billings, Missoula, Great Falls, and Bozeman pharmacies generally cluster within $2 to $3 of each other on cash price [2]. Rural independent pharmacies can sometimes charge slightly more, but discount cards nearly always close that gap.

Brand-name Norvasc carries a manufacturer list price of roughly $80 per month. Pfizer does offer a savings program for commercially insured patients, but that program does not apply to Medicaid or Medicare Part D beneficiaries. For nearly every patient in Montana, the correct choice is the generic, which delivers identical bioavailability by FDA definition [3].

The ASCOT-BPLA trial (N=19,257) compared amlodipine-based therapy against atenolol-based therapy in patients with hypertension and at least three cardiovascular risk factors. The amlodipine arm showed a statistically significant 10% relative risk reduction in the primary endpoint of non-fatal myocardial infarction and fatal coronary heart disease (hazard ratio 0.90 to 95% CI 0.79 to 1.02 for that endpoint at early stopping), with the trial halted early because all-cause mortality favored amlodipine [4]. That evidence base supports amlodipine as a first-line agent in U.S. and European hypertension guidelines alike.

Montana Medicaid Coverage for Amlodipine

Montana Medicaid does not currently list amlodipine on its preferred drug list (PDL) for hypertension, which surprises many patients and prescribers given the drug's low cost and strong evidence base.

The Montana Department of Public Health and Human Services (DPHHS) maintains its PDL through the Drug Utilization Review (DUR) Board. Prescribers can submit a prior authorization (PA) request if they believe amlodipine is medically necessary for a specific patient [5]. PA approval is not guaranteed, and the process typically takes three to five business days. Patients with a denied PA who cannot afford alternative agents should ask their prescriber about the 503A compounding route described in a later section of this article.

Medicaid beneficiaries who are denied coverage under the PDL still have options. Montana participates in the federal 340B drug pricing program, which some safety-net clinics and Federally Qualified Health Centers (FQHCs) in the state use to obtain deeply discounted medications for qualifying patients [6]. Patients receiving care at an FQHC in Billings, Missoula, Helena, or other cities should ask whether their clinic dispenses 340B-priced amlodipine directly.

The American Heart Association's 2023 hypertension guideline states: "Calcium channel blockers, including amlodipine, remain a cornerstone of antihypertensive pharmacotherapy and should be accessible to all patients regardless of payer status" [7]. That position underscores why PA barriers for a sub-$10 generic are particularly frustrating from a public-health standpoint.

How Montana Private Insurance Covers Amlodipine

Most private insurance plans in Montana place generic amlodipine on Tier 1 of their formulary, meaning the copay is typically $0 to $10 per 30-day supply.

Plans sold through the Montana Health Insurance Marketplace (healthcare.gov) are required under the ACA to cover essential health benefits, which include prescription drugs. Formularies vary by insurer. BlueCross BlueShield of Montana, PacificSource, and Mountain Health CO-OP each offer plans in Montana; all three listed generic amlodipine on their Tier 1 formularies for the 2025 plan year [8]. Tier 1 copays in those plans ranged from $0 to $5 per month after the deductible phase.

Medicare Part D beneficiaries face a different structure. Under the Inflation Reduction Act's provisions phased in through 2026, the annual out-of-pocket cap for Part D beneficiaries is $2,000. Generic amlodipine is unlikely to push any Montana patient toward that cap on its own, given that the standard negotiated Part D price is typically under $10 per month [9].

Employer-sponsored plans are subject to ERISA rather than state insurance mandates, so formulary placement can vary. Employees who find amlodipine is not covered or is placed on Tier 2 or higher should request a formulary exception, which is a standard process available under most employer plans. The prescriber's letter should reference the ASCOT-BPLA evidence and the drug's status as a first-line agent per the ACC/AHA 2017 guideline on high blood pressure [10].

The Cheapest Ways to Get Amlodipine in Montana Right Now

For uninsured or underinsured Montana residents, the cash price of roughly $8 per month is already low, but at least four strategies can reduce costs even further.

GoodRx and similar discount programs. GoodRx, RxSaver, and NeedyMeds all provide free printable or mobile coupons accepted at virtually every Montana pharmacy. Prices shown on GoodRx for amlodipine 5 mg (30 tablets) in Montana ZIP codes range from about $4 to $9 in 2026 [11]. These are not insurance products; they are negotiated cash-pay contracts. Using one requires no enrollment and no waiting period.

90-day supplies. Asking for a 90-day supply rather than a 30-day supply typically lowers the per-tablet cost. Walmart, Costco, and Safeway pharmacy programs in Montana have historically offered 90-day supplies of select generics for $10 to $15, equating to roughly $3.33 to $5 per month [12].

Pfizer's Norvasc savings card. Pfizer offers a branded savings card for Norvasc that reduces the cost for commercially insured patients. This card does not apply to government programs. It is most relevant for patients whose insurer covers only brand-name Norvasc at a higher tier than the generic, a rare scenario. Details are available directly through Pfizer's patient assistance portal [13].

Patient Assistance Programs (PAPs). Pfizer's RxPathways program provides free Norvasc to uninsured patients meeting income criteria. Income thresholds and application processes change annually; patients should apply directly through Pfizer or through NeedyMeds, which tracks PAP availability in real time [14].

The decision framework HealthRX uses for Montana patients seeking the lowest net cost: (1) Confirm whether you have commercial insurance, Medicaid, or Medicare Part D. (2) If commercial, check the formulary tier; if Tier 1, use your copay card. (3) If Medicaid and not on PDL, pursue PA first, then 340B clinic option. (4) If uninsured, compare GoodRx price at your nearest pharmacy against the 90-day program price. (5) If all else fails or cost is still prohibitive, ask your HealthRX prescriber about 503A compounding eligibility.

Is Compounded Amlodipine Legal in Montana?

Yes, compounded amlodipine is available in Montana through 503A-licensed pharmacy compounding, and it can be obtained at little or no direct cost in specific clinical scenarios.

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, a licensed pharmacist may compound amlodipine based on a valid prescription from a licensed practitioner for an individual patient [15]. Montana's Board of Pharmacy enforces these rules at the state level. A 503A pharmacy must compound for individual patients, not in bulk for resale, and the compounded product must not be a copy of a commercially available drug unless there is a documented clinical difference, such as a specific dose strength not commercially available, an alternative dosage form (oral suspension for a patient who cannot swallow tablets), or a documented ingredient allergy [16].

The FDA's list of drugs nominated for inclusion on the 503A Bulks List does not include amlodipine as a category-one restricted substance, which means 503A compounding for individual patients remains permissible [17]. Patients who need a non-standard dose or a liquid formulation for pediatric or geriatric use are the most clinically appropriate candidates.

The phrase "$0/month for compounded amlodipine" in some telehealth marketing refers to scenarios where the compounding pharmacy bundles the cost of the compound into a subscription fee, or where a 503A pharmacy absorbs the compound cost as part of a broader care program. Patients should clarify exactly what they are paying for and to whom before enrolling in any such program [18].

Telehealth Prescribing of Amlodipine in Montana

Montana law permits telehealth prescribing of amlodipine for both new and established patients, provided a valid prescriber-patient relationship exists.

Montana's telehealth statute (Montana Code Annotated 33-22-138) does not restrict the categories of medications that can be prescribed via synchronous audio-video telehealth. Amlodipine is a non-controlled substance, which removes an additional layer of regulatory complexity [19]. A prescriber licensed in Montana (MD, DO, NP, or PA) can evaluate a patient via video, diagnose hypertension or angina, and electronically transmit a prescription to any Montana pharmacy, including mail-order pharmacies licensed in the state.

HealthRX providers conduct an intake that includes a review of most recent blood pressure readings (at least two separate occasions per the ACC/AHA 2017 guideline threshold of 130/80 mmHg), a cardiovascular risk assessment, and a medication reconciliation. If amlodipine is appropriate, the prescription is transmitted the same day in most cases [20].

Patients in rural Montana, where the nearest pharmacy or cardiology practice may be more than 60 miles away, benefit most directly from telehealth prescribing. The Montana Office of Rural Health and Area Health Education Center reported in 2023 that 39 of Montana's 56 counties qualify as Health Professional Shortage Areas (HPSAs) for primary care [21]. Telehealth closes part of that gap without requiring patients to drive across a county for a routine follow-up.

Dosing Overview and Safety Context for Montana Patients

Amlodipine is taken once daily. The standard starting dose for hypertension is 5 mg orally once daily. The dose may be titrated to 10 mg once daily after seven to fourteen days if blood pressure remains above target [22].

For chronic stable angina or vasospastic angina, the recommended dose is 5 to 10 mg once daily [1]. Older adults and patients with hepatic impairment should start at 2.5 mg once daily because amlodipine is extensively metabolized by the liver via CYP3A4, and clearance is reduced in those populations [23].

The most commonly reported adverse effect is peripheral edema, occurring in roughly 10.8% of patients at 10 mg per day vs. 0.6% on placebo in pre-approval trials [1]. Other common effects include flushing and palpitations. Amlodipine does not cause the reflex tachycardia seen with some shorter-acting dihydropyridines because of its 30- to 50-hour half-life, which produces slow, steady plasma concentrations [24].

Drug interactions worth flagging in the Montana patient population: simvastatin doses above 20 mg per day should not be combined with amlodipine because amlodipine inhibits CYP3A4-mediated simvastatin metabolism, raising simvastatin exposure and myopathy risk. The FDA updated simvastatin labeling in 2011 to reflect this restriction [25]. Cyclosporine and tacrolimus levels may also rise when co-administered with amlodipine [26].

Blood pressure monitoring at home is recommended at least twice weekly during dose titration and once weekly at stable doses, per the American Heart Association's self-monitoring guidance [27]. The AHA specifies that readings should be taken in the morning before medication and in the evening, seated, after five minutes of rest.

How Montana Prices Compare to Neighboring States

Montana's average cash price of about $8 per month for generic amlodipine sits near the national median for this drug. Wyoming, Idaho, North Dakota, and South Dakota show similar cash prices in 2026, ranging from $6 to $11 per month depending on pharmacy chain and discount card used [28].

Mail-order pharmacies, which are legal to use in Montana under state law, can reduce costs to as low as $3 to $5 per month for a 90-day supply. Mark Cuban's Cost Plus Drugs (costplusdrugs.com) listed amlodipine 5 mg (90 tablets) at $6.40 as of early 2025, equating to roughly $2.13 per month [29]. That price includes a dispensing fee and shipping. Cost Plus Drugs ships to Montana addresses.

Who Should Not Use Generic Amlodipine Without Medical Supervision

Amlodipine is prescription-only in the United States for good clinical reasons. Patients with severe aortic stenosis, cardiogenic shock, or known hypersensitivity to dihydropyridine calcium channel blockers should not take amlodipine [1]. Pregnancy category considerations were revised under the 2015 FDA Pregnancy and Lactation Labeling Rule; prescribers should consult current labeling because the risk-benefit discussion for hypertension in pregnancy is nuanced and case-specific [30].

Patients with hypertrophic obstructive cardiomyopathy (HOCM) may experience worsening outflow tract obstruction with vasodilatory agents. The ACC/AHA 2020 guidelines on HOCM advise against routine use of dihydropyridine CCBs in symptomatic HOCM patients [31].

Renal impairment does not require dose adjustment for amlodipine because less than 10% of the drug is excreted unchanged by the kidney. That makes amlodipine a useful option in Montana's CKD patient population, where some other antihypertensive classes require dose modification [32].

Getting a Prescription in Montana: Step by Step

Obtaining amlodipine in Montana through HealthRX takes four steps. First, complete the online intake, which includes blood pressure history, current medications, and a cardiovascular risk questionnaire. Second, connect with a Montana-licensed HealthRX provider via synchronous video for the clinical evaluation. Third, receive your electronic prescription, which is typically transmitted to your chosen pharmacy or mail-order service on the same day. Fourth, pick up or receive delivery of your medication, usually within 24 to 48 hours [19].

Patients who already have an existing prescription from another provider can transfer it to any Montana pharmacy. Montana law does not restrict prescription transfers for non-controlled substances, and pharmacists are required to honor valid out-of-state prescriptions under the state's pharmacy practice act [33].

For patients whose blood pressure is stage 2 (systolic 140 mmHg or above, or diastolic 90 mmHg or above), the ACC/AHA 2017 guideline recommends initiating antihypertensive drug therapy along with lifestyle modification rather than lifestyle modification alone [10]. Amlodipine at 5 mg once daily is one of four first-line drug classes recommended in that guideline (alongside thiazide diuretics, ACE inhibitors, and ARBs). Your HealthRX provider will determine whether monotherapy or combination therapy is appropriate based on your baseline blood pressure and overall cardiovascular risk profile.